Captrust Financial Advisors Abiomed Inc Transaction History

Captrust Financial Advisors

$33 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 16, 2022	SELL	$242.49 - $301.46 $32,251 - $40,094	-133 Reduced 8.46%	1,439 $354,000
Q2 2022 Aug 23, 2022	SELL	$224.73 - $338.64 $24,495 - $36,911	-109 Reduced 6.48%	1,572 $389,000
Q2 2022 Aug 16, 2022	SELL	$224.73 - $338.64 $916,673 - $1.38 Million	-4,079 Reduced 70.82%	1,681 $416,000
Q1 2022 May 16, 2022	BUY	$277.25 - $366.29 $1.3 Million - $1.72 Million	4,686 Added 436.31%	5,760 $1.91 Million
Q4 2021 Feb 14, 2022	SELL	$300.63 - $371.35 $35,774 - $44,190	-119 Reduced 9.97%	1,074 $386,000
Q3 2021 Nov 16, 2021	SELL	$310.19 - $376.2 $47,769 - $57,934	-154 Reduced 11.43%	1,193 $388,000
Q2 2021 Aug 16, 2021	SELL	$262.71 - $351.17 $72,770 - $97,274	-277 Reduced 17.06%	1,347 $420,000
Q1 2021 May 17, 2021	BUY	$285.92 - $355.13 $182,416 - $226,572	638 Added 64.71%	1,624 $518,000
Q4 2020 Feb 16, 2021	BUY	$251.88 - $324.2 $23,928 - $30,799	95 Added 10.66%	986 $320,000
Q3 2020 Nov 17, 2020	BUY	$255.22 - $317.0 $63,549 - $78,933	249 Added 38.79%	891 $232,000
Q2 2020 Aug 14, 2020	BUY	$141.4 - $257.09 $90,778 - $165,051	642 New	642 $164,000
Q4 2019 Feb 14, 2020	SELL	$159.31 - $223.54 $50,501 - $70,862	-317 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$175.89 - $279.23 $21,810 - $34,624	124 Added 64.25%	317 $56,000
Q2 2019 Aug 13, 2019	BUY	$250.96 - $284.94 $40,153 - $45,590	160 Added 484.85%	193 $50,000
Q1 2019 May 15, 2019	SELL	$276.39 - $362.25 $19,347 - $25,357	-70 Reduced 67.96%	33 $9,000
Q4 2018 Feb 13, 2019	BUY	$281.08 - $444.25 $26,702 - $42,203	95 Added 1187.5%	103 $33,000
Q2 2018 Aug 13, 2018	SELL	$278.07 - $446.21 $21,411 - $34,358	-77 Reduced 90.59%	8 $3,000
Q1 2018 May 15, 2018	BUY	$192.49 - $295.85 $16,361 - $25,147	85 New	85 $24,000

Others Institutions Holding ABMD

# of Institutions

Shares Held

137K

Call Options Held

Put Options Held

View Full List

About ABIOMED INC

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

More about ABMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.

Account